Summary Survival rates for 67 women with bilateral breast cancer were compared to those for 1282 women with unilateral disease in a follow-up of 1349 women participating in a population-based study. Relative survival at 8 years of follow-up was 69% for women with unilateral disease as compared to 53% for women with bilateral cancer. When possible confounding histopathological differences -data about which were prospectively collected -and age were adjusted for in a multivariate analysis, the relative hazard rate was significantly higher for women with bilateral versus unilateral breast cancer (P=0.006). The al., 1984; Turco et al., 1982) . However, the findings in several studies of these survival rates are afflicted with uncertainty on account of selection of the patient material, lack of control of confounding factors and inadequate statistical methods.
Summary Survival rates for 67 women with bilateral breast cancer were compared to those for 1282 women with unilateral disease in a follow-up of 1349 women participating in a population-based study. Relative survival at 8 years of follow-up was 69% for women with unilateral disease as compared to 53% for women with bilateral cancer. When possible confounding histopathological differences -data about which were prospectively collected -and age were adjusted for in a multivariate analysis, the relative hazard rate was significantly higher for women with bilateral versus unilateral breast cancer (P=0.006). The impact of interval time between the two primaries was analysed and a roughly two-fold higher hazard rate was seen for synchronous cancers with regularly falling risk for increasing interval times. This trend was however not statistically significant. The results indicate that the two tumours contribute independently to the patient's excess risk of dying and thus occur as two seemingly biologically unrelated events with respect to the tumourhost relationship and metastatic behaviour.
The reported survival rates for women with bilateral breast cancer as compared with women with unilateral cancer have varied considerably. Both similar prognosis (Schell et al., 1982; Slack et al., 1973; Nielsen et al., 1986; and a poorer prognosis (Robbins et al., 1964) in bilateral cancer have been found. In some studies the results of the comparisons varied, depending on whether the cancers were synchronous or metachronous (McCredie et al., 1975; Bailey et al., 1980; Burns et al., 1984; Turco et al., 1982) . However, the findings in several studies of these survival rates are afflicted with uncertainty on account of selection of the patient material, lack of control of confounding factors and inadequate statistical methods.
We addressed these questions specifically in a long-term follow-up of women participating in a population-based case-control study which included nearly all incident cases of breast cancer from one third of the Swedish population diagnosed during a 14-month period (Adami et al., 1985) . The observed and relative survival were compared between women with bilateral and those with unilateral breast cancer. The influence of the time interval between diagnosis of the two cancers was also analyzed. Confounding factors were taken into account by multivariate techniques.
Materials and methods

Patients
All incident cases of breast cancer were registered continuously during a 14-month period in 1977-78 for the purpose of a case-control study (Adami et al., 1985) . The study was population-based and covered nearly one-third of the total Swedish population.
During the study period 1,423 incident cases were registered. Within two months after diagnosis a questionnaire was mailed to all patients in order to obtain information on epidemiologic characteristics. Twenty-three women had died, 37 did not respond to the questionnaire and 14 gave incomplete answers. Histopathologic evaluation All available slides were re-examined blindly by one and the same pathologist. The histologic classification according to Ackerman et al. (1974) was used. The following characteristics were coded according to standardized, predetermined criteria and subsequently computerized: Histologic type (ductal, lobular, papillary, colloid, medullary, tubular and adenoid cystic cancers); Ackerman classification; tumour grade; cellular pleomorphism; presence of lympho-plasmocytic cellular infiltrates in and around the cancer (graded as none, slight, moderate or high). Histopathological tumour size and multicentricity could not be reliably recorded, since the pathologist had only access to the histopathological slides. Vascular invasion is one of the separate measures classifying a tumour into group IV according to Ackerman. When information from the axilla was available, number of axillary nodes with cancer involvement, presence of periglandular metastatic growth, and sinus histiocytosis were recorded.
A unique 10-digit national registration number (NRN) is allocated to every Swedish citizen, and includes the date of birth. In 1986, the NRN of every patient in the cohort was checked and corrected if necessary. As a result, all women could be followed up with respect to survival until June 1986 through computerized linkage to two national registers, viz. the Causes of Death Register and a continuously updated population register. By these combined means, all women could be identified either as still alive at the end of the observation period or as deceased. In the latter case, the date of death was copied into the cohort data file. Survival was the only end-point of interest. We therefore made no attempt to carry out individual follow-up with respect to other outcomes.
Analyses
The observed survival rates for all causes of death were calculated by the actuarial (life-table) method, and the breast cancer-specific mortality was determined by computing the relative survival. The relative survival rates were calculated as the ratio of the observed to the expected rates. The expected survival rates were calculated from life tables compiled according to 5-year age group, and 5-year calendar period for the total female population of Sweden (Hakulinen et al., 1985) .
The annual conditional probability of death from breast cancer was computed as the complement of annual relative survival. The standard error of the observed survival rate was computed from Greenwood's formula and the standard error of the relative survival was computed as described by Ederer et al. (1961) . Ninety-five percent confidence limits were used to estimate uncertainty in the calculated survival rates.
Multivariate analyses In order to compare the survival of women with bilateral and unilateral cancer while taking into account other variables, the Cox proportional hazards model was used. The basic model assumes that the hazard h(tlx) can be written h(tlx)=hO(t)exp(fi1xj+ ...+fkxk), where ho(t) is a baseline hazard function for individuals with all explanatory variables X1,....,Xk equal to 0. The parameter f3i shows the change in the logarithm of the hazard function as the variable xi increases by one unit, given that the other variables are unchanged. A positive value of fpi implies an increase in the hazard function, i.e., poorer survival prospects. The effect on the hazard associated with the variable xi is exp (fli). (Lawless, 1982) .
The effect of bilateral cancer was modelled in the following two basic ways: where D is an indicator variable taking the value 1 for a bilateral cancer and 0 otherwise, while TIME is the time in years between diagnosis of the first and second primary cancer. Model B allows a non-linear effect of TIME. The parameter 111 shows the relative hazard for synchronous bilateral cancer.
Results
Overall and relative survival Figure 1 shows the life table curves for observed survival rates in the groups with bilateral and unilateral disease. The relative survival curves are shown in Figure 2 . There was no statistically significant difference between the two groups for either measure.
Years Figure 2 Relative survival for women with unilateral (0) and bilateral (A) breast cancer. 95% confidence intervals at 5-and 8-year follow-up are given in the figure. Relative survival at 8 years was 0.694 for unilateral and 0.526 for bilateral cancer. The difference is not statistically significant.
Multivariate analyses In the first set of multivariate models, only age at diagnosis was taken into account as a possible confounding factor (the unadjusted models in Table I ). In model 1, the prognosis for all women with bilateral cancer was compared with that for women with unilateral disease. Those with bilateral cancer were found to have a poorer prognosis, but the difference did not reach the 5% level of significance. In model 2 the interval between the first and second primary cancer was taken into account. The same was done in model 3, but here the influence of time was (f12) in models A and B; cP=0.064; dp =0.006; P =0.033; fP = 0.003; gP = 0.019.
analyzed under the assumption that the prognosis changed in a logarithmic way. In both these models the hazard rate was found to be highest for women with synchronous bilateral disease and tended to decrease with a widening interval between the two diagnoses. The trend was not statistically significant, however (Table I) .
The second set of multivariate models (the adjusted models in Table I ) was estimated by taking age, all histopathologic characteristics of the mastectomy specimen, and the axillary node status (when available) at the second breast cancer into account as possible confounding factors. The same pattern as in the first set of models appeared, but was more pronounced. The overall increase in hazard rate associated with a second breast cancer was now statistically significant (Table I) .
The effects of the time interval on the relative hazards shown in Table I are presented in Table II for different intervals (years). There was a consistent decrease in the relative hazard over the years from a two-fold increase for synchronous cancers to 1.5 and 1.0-1.2 on extrapolation to 10 and 30 years respectively. The findings were similar whether time was incorporated in the model as a logarithmic function or not. The trend is not statistically significant, however.
Discussion
The women with bilateral breast cancer in this analysis were drawn from a population-based study comprising nearly all incident cases during a period of 14 months from one third of the Swedish population. The recruitment time was thus short and all diagnoses of the second breast cancer were based on cytologic and/or histologic findings. The histopathologic examinations were standardized. Tumour size was not recorded, but there is no reason to believe that tumour size for the second cancer in women with bilateral breast cancers should be biased as compared to women with unilateral disease. The differences in treatment were small and not of a magnitude expected to introduce bias. The follow-up was complete. Reliable background data were available for computing the relative survival rate. The occurrence of bilateral cancer was of the prevalence expected, but the total number of 66 does not give high statistical power. In the analyses possibly important confounding factors could be taken into account by multivariate techniques.
The main finding in this study was that women with bilateral breast cancer have a poorer prognosis than those with unilateral disease. We found a relative hazard close to two for synchronous cancer, with a regularly falling trend for metachronous cancer with an increased interval between diagnosis of the first and second tumour. Though not statistically significant, this trend was consistent in different multivariate models.
The Cox model assumes that the relative hazard associated with a prognostic variable is the same irrespective of the length of time after diagnosis. This is not necessarily true and methods exist for relaxing this assumption. However, the small number of observed bilateral cancers in our material makes the statistical power of such analyses so low that no attempt at estimation was made.
Our results are consistent with the findings of Robbins and Berg for bilateral breast cancer (Robbins et al., 1964) . In life-table analyses and matched comparisons with unilateral cancer cases, they also found that the second cancer added a seemingly independent risk. The generally poor prognosis for women with bilateral cancer diminished when the interval between the two diagnoses increased. Their conclusions were drawn, however, from the findings in a hospital-based series.
In three other studies (McRedie et al., 1975; Bailey et al., 1980; Burns et al., 1984) it has been observed that patients with synchronous cancers fare badly, while the prognosis for women with metachronous cancers is better. But in these studies, metachronous bilateral disease seemed to entail a prognosis similar to that in unilateral cancer when survival was calculated from the date of the second diagnosis as in our study. The discrepancies between our results and those of the latter studies might have been smaller, however, if they had taken into account both age and disease stage (McCredie et al., 1975; Bailey et al., 1980; Burns et al., 1984) or had used a life-table technique for computing the survival (McCredie et al., 1975) . This assumption is suggested by our finding that correction for age alone gave less marked differences between unilateral and bilateral cases. Further-more, age influences survival, the prognosis being better for women aged 40-49 (Adami et al., 1986; , and this age group is more frequently represented among women with bilateral disease Adami et al., 1985) . In another study (Turco et al., 1982) a poorer prognosis was found for women with bilateral disease, butcontrary to our results and those mentioned above -patients with metachronous cancer fared worse than those with synchronous tumours. The women in that study were referral patients only and this might have introduced bias.
In four studies (Schell et al., 1982; Slack et al., 1973; Nielsen et al., 1986; it was found that the survival was similar for women with bilateral and unilateral disease. The study design and analyses differed in major respects, however, from those of the present investigation, which might explain the contradictory findings. In two of them only patients with stage I and II disease were included (Schell et al., 1982; Slack et al., 1973) . Furthermore, one report was based on a hospital series (Schell et al., 1982) and the other on patients recruited to a randomized trial (Slack et al., 1973 Adami et al., 1986; . These particularities in study design make it difficult to judge the external validity of these findings vis-ai-vis results for population-based incident cases.
Three further reports (Finney et al., 1972; Harrington, 1953 , Lesser et al., 1982 comment upon the prognosis for women with bilateral cancer. The presentations and statistical methods do not, however, permit an evaluation of their external and internal validity and thus make comparisons with our results impossible.
Thus, the findings in the present investigation are supported by other evidence in the literature and we agree with Robbins and Berg (Robbins et al., 1964) that the pattern observed is plausible from a biological standpoint: The second cancer adds an additional risk of dying which is close to two-fold if the cancers are synchronous or occur very near in time. The risk of dying from the first breast cancer then declines as the interval between the two tumours increases, since only women with a reasonably good prognosis live long enough to experience bilateral disease.
